Biology:Complement component 5
Generic protein structure example |
Complement component 5 is a protein that in humans is encoded by the C5 gene.[1]
Complement component 5 is involved in the complement system. It is cleaved into C5a and C5b:
- C5a plays an important role in chemotaxis.[2]
- C5b forms the first part of the complement membrane attack complex.
Deficiency is thought to cause Leiner's disease.
Function
Complement component 5 is the fifth component of complement, which plays an important role in inflammatory and cell killing processes. This protein is composed of alpha and beta polypeptide chains that are linked by a disulfide bridge. An activation peptide, C5a, which is an anaphylatoxin that possesses potent spasmogenic and chemotactic activity, is derived from the alpha polypeptide via cleavage with a C5-convertase. The C5b macromolecular cleavage product can form a complex with the C6 complement component, and this complex is the basis for formation of the membrane attack complex, which includes additional complement components.[1]
Clinical significance
Mutations in this gene cause complement component 5 deficiency, a disease where patients show a propensity for severe recurrent infections. Defects in this gene have also been linked to a susceptibility to liver fibrosis and to rheumatoid arthritis.[1]
Therapeutic applications
The drug eculizumab (trade name Soliris) prevents cleavage of C5 into C5a and C5b.[3]
Complement system pathway

References
- ↑ 1.0 1.1 1.2 "C5 complement C5 (Homo sapiens (human)) Gene ID: 727". 29 November 2020. https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=ShowDetailView&TermToSearch=727.
- ↑ Immunology at MCG 1/phagocyt[|permanent dead link|dead link}}]
- ↑ "Eculizumab". Br J Clin Pharmacol 68 (3): 318–319. 2009. doi:10.1111/j.1365-2125.2009.03491.x. PMID 19740388.
Further reading
- "Fifth component of human complement: purification from plasma and polypeptide chain structure". Biochemistry 18 (8): 1490–7. 1979. doi:10.1021/bi00575a016. PMID 106884.
- "Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a". J. Biol. Chem. 253 (19): 6955–64. 1978. doi:10.1016/S0021-9258(17)38013-4. PMID 690134.
- DiScipio RG (1992). "Formation and structure of the C5b-7 complex of the lytic pathway of complement". J. Biol. Chem. 267 (24): 17087–94. doi:10.1016/S0021-9258(18)41897-2. PMID 1387399.
- "Complete cDNA sequence of human complement pro-C5. Evidence of truncated transcripts derived from a single copy gene". J. Immunol. 146 (1): 362–8. 1991. doi:10.4049/jimmunol.146.1.362. PMID 1984448.
- "Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus". Biochem. J. 273 (Pt 3): 635–40. 1991. doi:10.1042/bj2730635. PMID 1996961.
- "Isolation and sequence analysis of a cDNA clone encoding the fifth complement component". J. Biol. Chem. 260 (4): 2108–12. 1985. doi:10.1016/S0021-9258(18)89523-0. PMID 2579066.
- "Heteronuclear three-dimensional NMR spectroscopy of the inflammatory protein C5a". Biochemistry 28 (6): 2387–91. 1989. doi:10.1021/bi00432a008. PMID 2730871.
- "Tertiary structure of human complement component C5a in solution from nuclear magnetic resonance data". Biochemistry 28 (1): 172–85. 1989. doi:10.1021/bi00427a025. PMID 2784981.
- "Complete primary structure and functional characterization of the sixth component of the human complement system. Identification of the C5b-binding domain in complement C6". J. Biol. Chem. 264 (30): 18041–51. 1989. doi:10.1016/S0021-9258(19)84676-8. PMID 2808363.
- "Molecular analysis of human complement component C5: localization of the structural gene to chromosome 9". Biochemistry 27 (5): 1474–82. 1988. doi:10.1021/bi00405a012. PMID 3365401.
- "Sequence-specific assignments in the 1H NMR spectrum of the human inflammatory protein C5a". Biochemistry 27 (10): 3568–80. 1988. doi:10.1021/bi00410a007. PMID 3408713.
- "Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement". J. Immunol. 139 (6): 1960–4. 1987. doi:10.4049/jimmunol.139.6.1960. PMID 3624872.
- "Mitogen-activated protein kinase activation requires two signal inputs from the human anaphylatoxin C5a receptor". J. Biol. Chem. 270 (34): 19828–32. 1995. doi:10.1074/jbc.270.34.19828. PMID 7649993.
- "[Chemico-enzymatic synthesis, cloning and expression of a gene for an analog of human anaphylatoxin C5a]". Bioorg. Khim. 21 (5): 359–64. 1995. PMID 7661861.
- "Inherited human complement C5 deficiency. Nonsense mutations in exons 1 (Gln1 to Stop) and 36 (Arg1458 to Stop) and compound heterozygosity in three African-American families". J. Immunol. 154 (10): 5464–71. 1995. doi:10.4049/jimmunol.154.10.5464. PMID 7730648.
- "Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors". Immunology 82 (4): 516–21. 1995. PMID 7835913.
- "Complement activation by recombinant HIV-1 glycoprotein gp120". J. Immunol. 152 (12): 6028–34. 1994. doi:10.4049/jimmunol.152.12.6028. PMID 7911492.
- "Antibodies against the C2 COOH-terminal region discriminate the active and latent forms of the multicatalytic proteinase complex". J. Biol. Chem. 269 (17): 12858–64. 1994. doi:10.1016/S0021-9258(18)99955-2. PMID 8175701.
- "Identification of complement activation sites in human immunodeficiency virus type-1 glycoprotein gp120". Blood 87 (6): 2329–36. 1996. doi:10.1182/blood.V87.6.2329.bloodjournal8762329. PMID 8630395.
- "Molecular cloning and characterization of the human anaphylatoxin C3a receptor". J. Biol. Chem. 271 (34): 20231–4. 1996. doi:10.1074/jbc.271.34.20231. PMID 8702752.
- "Structure of and influence of a tick complement inhibitor on human complement component 5". Nat Immunol 9 (7): 753–60. 2008. doi:10.1038/ni.1625. PMID 18536718.
External links
- Complement+5 at the US National Library of Medicine Medical Subject Headings (MeSH)
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
